Cargando…
Defining Antibody Seroprevalence and Duration of Humoral Responses to SARS-CoV-2 Infection and/or Vaccination in a Greek Community
Background: In this work, we aimed to evaluate antibody-response longevity to SARS-CoV-2 infection and/or vaccination in one of the Greek communities that was worst hit by the pandemic, Deskati, five months after a previous serosurveillance and nine months after the pandemic wave initiation (October...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744770/ https://www.ncbi.nlm.nih.gov/pubmed/35010667 http://dx.doi.org/10.3390/ijerph19010407 |
_version_ | 1784630188189941760 |
---|---|
author | Kotsiou, Ourania S. Papagiannis, Dimitrios Fradelos, Evangelos C. Siachpazidou, Dimitra I. Perlepe, Garifallia Miziou, Angeliki Kyritsis, Athanasios Vavougios, George D. Kalantzis, Georgios Gourgoulianis, Konstantinos I. |
author_facet | Kotsiou, Ourania S. Papagiannis, Dimitrios Fradelos, Evangelos C. Siachpazidou, Dimitra I. Perlepe, Garifallia Miziou, Angeliki Kyritsis, Athanasios Vavougios, George D. Kalantzis, Georgios Gourgoulianis, Konstantinos I. |
author_sort | Kotsiou, Ourania S. |
collection | PubMed |
description | Background: In this work, we aimed to evaluate antibody-response longevity to SARS-CoV-2 infection and/or vaccination in one of the Greek communities that was worst hit by the pandemic, Deskati, five months after a previous serosurveillance and nine months after the pandemic wave initiation (October 2020). Methods: The SARS-CoV-2 IgG II Quant method (Architect, Abbott, IL, USA) was used for antibody testing. Results: A total of 69 subjects, who previously tested positive or negative for COVID-19 antibodies, participated in the study. We found that 48% of participants turned positive due to vaccination. 27% of participants were both previously infected and vaccinated. However, all previously infected participants retained antibodies to the virus, irrespective of their vaccination status. The antibody titers were significantly higher in previously infected participants that had been vaccinated than those who were unvaccinated and in those that had been previously hospitalized for COVID-19 than those with mild disease. Conclusions: Antibody responses to SARS-CoV-2 infection were maintained nine months after the pandemic. Vaccination alone had generated an immune response in almost half of the population. Higher antibody titers were found in the case of vaccination in previously infected subjects and especially in those with severe disease leading to hospitalization. |
format | Online Article Text |
id | pubmed-8744770 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87447702022-01-11 Defining Antibody Seroprevalence and Duration of Humoral Responses to SARS-CoV-2 Infection and/or Vaccination in a Greek Community Kotsiou, Ourania S. Papagiannis, Dimitrios Fradelos, Evangelos C. Siachpazidou, Dimitra I. Perlepe, Garifallia Miziou, Angeliki Kyritsis, Athanasios Vavougios, George D. Kalantzis, Georgios Gourgoulianis, Konstantinos I. Int J Environ Res Public Health Article Background: In this work, we aimed to evaluate antibody-response longevity to SARS-CoV-2 infection and/or vaccination in one of the Greek communities that was worst hit by the pandemic, Deskati, five months after a previous serosurveillance and nine months after the pandemic wave initiation (October 2020). Methods: The SARS-CoV-2 IgG II Quant method (Architect, Abbott, IL, USA) was used for antibody testing. Results: A total of 69 subjects, who previously tested positive or negative for COVID-19 antibodies, participated in the study. We found that 48% of participants turned positive due to vaccination. 27% of participants were both previously infected and vaccinated. However, all previously infected participants retained antibodies to the virus, irrespective of their vaccination status. The antibody titers were significantly higher in previously infected participants that had been vaccinated than those who were unvaccinated and in those that had been previously hospitalized for COVID-19 than those with mild disease. Conclusions: Antibody responses to SARS-CoV-2 infection were maintained nine months after the pandemic. Vaccination alone had generated an immune response in almost half of the population. Higher antibody titers were found in the case of vaccination in previously infected subjects and especially in those with severe disease leading to hospitalization. MDPI 2021-12-31 /pmc/articles/PMC8744770/ /pubmed/35010667 http://dx.doi.org/10.3390/ijerph19010407 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kotsiou, Ourania S. Papagiannis, Dimitrios Fradelos, Evangelos C. Siachpazidou, Dimitra I. Perlepe, Garifallia Miziou, Angeliki Kyritsis, Athanasios Vavougios, George D. Kalantzis, Georgios Gourgoulianis, Konstantinos I. Defining Antibody Seroprevalence and Duration of Humoral Responses to SARS-CoV-2 Infection and/or Vaccination in a Greek Community |
title | Defining Antibody Seroprevalence and Duration of Humoral Responses to SARS-CoV-2 Infection and/or Vaccination in a Greek Community |
title_full | Defining Antibody Seroprevalence and Duration of Humoral Responses to SARS-CoV-2 Infection and/or Vaccination in a Greek Community |
title_fullStr | Defining Antibody Seroprevalence and Duration of Humoral Responses to SARS-CoV-2 Infection and/or Vaccination in a Greek Community |
title_full_unstemmed | Defining Antibody Seroprevalence and Duration of Humoral Responses to SARS-CoV-2 Infection and/or Vaccination in a Greek Community |
title_short | Defining Antibody Seroprevalence and Duration of Humoral Responses to SARS-CoV-2 Infection and/or Vaccination in a Greek Community |
title_sort | defining antibody seroprevalence and duration of humoral responses to sars-cov-2 infection and/or vaccination in a greek community |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744770/ https://www.ncbi.nlm.nih.gov/pubmed/35010667 http://dx.doi.org/10.3390/ijerph19010407 |
work_keys_str_mv | AT kotsiououranias definingantibodyseroprevalenceanddurationofhumoralresponsestosarscov2infectionandorvaccinationinagreekcommunity AT papagiannisdimitrios definingantibodyseroprevalenceanddurationofhumoralresponsestosarscov2infectionandorvaccinationinagreekcommunity AT fradelosevangelosc definingantibodyseroprevalenceanddurationofhumoralresponsestosarscov2infectionandorvaccinationinagreekcommunity AT siachpazidoudimitrai definingantibodyseroprevalenceanddurationofhumoralresponsestosarscov2infectionandorvaccinationinagreekcommunity AT perlepegarifallia definingantibodyseroprevalenceanddurationofhumoralresponsestosarscov2infectionandorvaccinationinagreekcommunity AT miziouangeliki definingantibodyseroprevalenceanddurationofhumoralresponsestosarscov2infectionandorvaccinationinagreekcommunity AT kyritsisathanasios definingantibodyseroprevalenceanddurationofhumoralresponsestosarscov2infectionandorvaccinationinagreekcommunity AT vavougiosgeorged definingantibodyseroprevalenceanddurationofhumoralresponsestosarscov2infectionandorvaccinationinagreekcommunity AT kalantzisgeorgios definingantibodyseroprevalenceanddurationofhumoralresponsestosarscov2infectionandorvaccinationinagreekcommunity AT gourgoulianiskonstantinosi definingantibodyseroprevalenceanddurationofhumoralresponsestosarscov2infectionandorvaccinationinagreekcommunity |